These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28855795)

  • 21. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).
    Umeda S; Suzuki MT; Okamoto H; Ono F; Mizota A; Terao K; Yoshikawa Y; Tanaka Y; Iwata T
    FASEB J; 2005 Oct; 19(12):1683-5. PubMed ID: 16099945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
    Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
    Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
    Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
    Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamics and subchronic toxicity in mice and monkeys of ISIS 388626, a second-generation antisense oligonucleotide that targets human sodium glucose cotransporter 2.
    Zanardi TA; Han SC; Jeong EJ; Rime S; Yu RZ; Chakravarty K; Henry SP
    J Pharmacol Exp Ther; 2012 Nov; 343(2):489-96. PubMed ID: 22915769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings.
    Ufret-Vincenty RL; Aredo B; Liu X; McMahon A; Chen PW; Sun H; Niederkorn JY; Kedzierski W
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5878-87. PubMed ID: 20538999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic modeling for hepatic delivery and efficacy of antisense oligonucleotides with lipophilic ligands in mice.
    Watanabe A; Katsube T
    Biopharm Drug Dispos; 2021 Apr; 42(4):178-187. PubMed ID: 33724506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys.
    Yu RZ; Gunawan R; Post N; Zanardi T; Hall S; Burkey J; Kim TW; Graham MJ; Prakash TP; Seth PP; Swayze EE; Geary RS; Henry SP; Wang Y
    Nucleic Acid Ther; 2016 Dec; 26(6):372-380. PubMed ID: 27500733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local and systemic tolerability of a 2'O-methoxyethyl antisense oligonucleotide targeting interleukin-4 receptor-α delivery by inhalation in mouse and monkey.
    Fey RA; Templin MV; McDonald JD; Yu RZ; Hutt JA; Gigliotti AP; Henry SP; Reed MD
    Inhal Toxicol; 2014 Jul; 26(8):452-63. PubMed ID: 24932560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of Bcl-xL in the survival of human RPE cells.
    Zhang N; Peairs JJ; Yang P; Tyrrell J; Roberts J; Kole R; Jaffe GJ
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3846-53. PubMed ID: 17652760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease of cone opsin mRNA in experimental ocular hypertension.
    Pelzel HR; Schlamp CL; Poulsen GL; Ver Hoeve JA; Nork TM; Nickells RW
    Mol Vis; 2006 Oct; 12():1272-82. PubMed ID: 17110910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the Liver.
    Donner AJ; Wancewicz EV; Murray HM; Greenlee S; Post N; Bell M; Lima WF; Swayze EE; Seth PP
    Nucleic Acid Ther; 2017 Aug; 27(4):209-220. PubMed ID: 28448194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of the liver-derived plasma protein fetuin-B mediates reversible female infertility.
    Floehr J; Dietzel E; Schmitz C; Chappell A; Jahnen-Dechent W
    Mol Hum Reprod; 2017 Jan; 23(1):34-44. PubMed ID: 27733488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.
    Passwell J; Schreiner GF; Nonaka M; Beuscher HU; Colten HR
    J Clin Invest; 1988 Nov; 82(5):1676-84. PubMed ID: 3183062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, IGF-I production and body weight gain in normal mice.
    Tachas G; Lofthouse S; Wraight CJ; Baker BF; Sioufi NB; Jarres RA; Berdeja A; Rao AM; Kerr LM; d'Aniello EM; Waters MJ
    J Endocrinol; 2006 Apr; 189(1):147-54. PubMed ID: 16614389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense inhibition of S6 kinase 1 produces improved glucose tolerance and is well tolerated for 4 weeks of treatment in rats.
    Younis HS; Hirakawa B; Scott W; Tran P; Bhat G; Affolter T; Chapman J; Heyen J; Chakravarty K; Alton G
    Pharmacology; 2011; 87(1-2):11-23. PubMed ID: 21178385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting murine alveolar macrophages by the intratracheal administration of locked nucleic acid containing antisense oligonucleotides.
    Uemura Y; Kobayashi K
    Drug Deliv; 2019 Dec; 26(1):803-811. PubMed ID: 31385541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.